Generic placeholder image

Applied Clinical Research, Clinical Trials and Regulatory Affairs (Discontinued)

Editor-in-Chief

ISSN (Print): 2213-476X
ISSN (Online): 2213-4778

Review Article

A Comprehensive Review of Regulatory Requirements and Registration Process of Pharmaceutical Drug Products in CIS Countries

Author(s): Kapil Pihwal*, Neelam Pawar, Sheikh Aamir, Mohammad Shahbaz Alam and Vikas Rathee

Volume 7 , Issue 3 , 2020

Page: [162 - 176] Pages: 15

DOI: 10.2174/2213476X07666200708105237

Price: $65

Abstract

Background: The CIS region has a potential market for India. The registration of the drug products in CIS regions is a challenging task because these countries have no harmonized regulatory organization. The CIS region includes 12 countries such as Russia, Kyrgyzstan, Ukraine, Uzbekistan, Kazakhstan, Tajikistan, Turkmenistan, Armenia, Azerbaijan, Belarus, Georgia and Moldova, which require different regulatory guidelines for medicinal product registration as per their FDA guidelines. The different guidelines for the same region become a challenging task for the manufacturer and exporter. The registration of the same product for different countries of CIS is not possible with the same dossier due to the lack of their regulatory harmonization. These countries obey their country-specific dossier format, so to target these market manufacturers and exporters needs to submit different dossier documents for different countries. But Ukraine and Kazakhstan have harmonization and it varies in Uzbekistan and Tajikistan. Ukraine and Kazakhstan are also imposing strict rules and expecting USFDA level documents for approval.

Conclusion: The overall conclusion is that harmonization in CIS is highly imbalanced, which affects both time and cost for product registration. Harmonization is the need of the era for easy product registration, and it will be beneficial for the manufacturer, regulator, importer, exporter, and to access medicines of high public health value.

Keywords: CIS region, drug product, guidelines, harmonization, regulatory, registration.

Graphical Abstract
[1]
Regulatory affairs [cited: December 29, 2019]. Available from: https://www.pharmaguideline.com/2012/12/regulatory-affai rs.html
[2]
Regulatory affairs EUPATI 2016. Available from: https://www.eupati.eu/glossary/regulatory-affairs/
[3]
Praneeth P. Regulatory affairs and its role in pharmaceutical industry. SSRG-IJPBE 2016; 3(1): 1-2.
[http://dx.doi.org/10.14445/23942576/IJPBE-V3I1P101]
[5]
Commonwealth of independent states 2019. Available from: http://www.cisstat.com/eng/cis.html
[6]
List of globally identified websites of medicines regulatory authorities. World Health Organization 2012. Available from: https://www.who.int/medicines/areas/quality_safety/regulation_legislation/list_mra_websites_nov2012.pdf Website:
[7]
List of authority websites – tarius – global regulatory requirements.. Available from: http://www.tarius.com/?page_id=612
[8]
[9]
ICH CTD. 2019. Available from: https://www.ich.org/page/ctd
[10]
Common technical document-pharma dossiers-ctd format perfect dossier. Available from: http://www.perfectdossier.com/ctd-dossiers.html
[11]
Jordan D. An overview of the Common Technical Document (CTD) regulatory dossier. Medical Writing 2014; 23(2): 101-5.
[http://dx.doi.org/10.1179/2047480614Z.000000000207]
[12]
Badjatya J. Overview of drug registration requirements for pharmaceuticals in emerging market. J Drug Deliv Ther 2011; 3(2): 227-32.
[http://dx.doi.org/10.22270/jddt.v3i2.466]
[13]
Handoo S, Arora V, Khera D, Nandi PK. Sahu SK. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int J Pharm Investig 2017; 2(3): 99-105.
[http://dx.doi.org/10.4103/2230-973X.104392] [PMID: 23373001]
[14]
Drug Registration of Pharmaceuticals in Russia Pharmabiz. . Available from: http://www.pharmabiz.com/Services/ExportImport/Countries/Russia.aspx
[15]
State registration of medicinal products in Russia. Mspcorporate. . Available from: https://mspcorporate.com/registration-medicinal-products-russia.html
[16]
. Sheftelevich Y, Tripathi S. Drug registration in Russia and the new law Available from: http://www.biomedconsult.com/201009focusrussia.pdf
[17]
Russia regulatory drug approval process lymphomacoalition.org . 2013. Available from: https://www.lymphomacoalition.org/docman2/leip-reports/leip-2013/350-russia-regulatory-and-funding-process-flowchart-october-2013
[19]
Russia: Key concerns of the pharmaceutical industry. Eksports. liaa.gov.lv. 2018. Available from: liaa.gov.lv http://eksports.liaa.gov.lv/files/liaa_export/attachments/efpia_russia_briefing_2018.pdf
[20]
Vashisth S, Singh G, Nanda A. A comparative study of regulatory trends of pharmaceuticals in Brazil, Russia, India and China (BRIC) countries. J Generic Med 2010; 9(3): 133-5.
[http://dx.doi.org/10.1177/1741134312459187]
[21]
Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. World Health Organization 2015. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/StabilityConditionsTable2UupdatedMarch2015.pdf?ua=1
[22]
Climatic zones for stability studies Pharmaguideline 2012. Available from: https://www.pharmaguideline.com/2010/12/different-climatic-zones-for-stability.html
[23]
Kazakhstan: pharmaceutical market overview. Khidicis.org.. 2019. Available from: http://khidicis.org/upload/files/38807_864055_17.pdf[15 June, 2020.]
[24]
Badjatya J, Bodla R, Musyuni P. Export Registration of Pharmaceuticals in Rest of World Countries (ROW). J Drug Deliv Ther 2013; 3(1): 61-4.
[25]
Registration of drugs in Ukraine: procedure, required documents and terms 2013. Available from: https://pravdop.com/en/publications/kommentarii-zakonodatelstva/registraciya-lekarstvennih-sredstv-v-ukraine-poryadok-dokumenti-sroki/
[26]
State registration of medicinal products in Ukraine. 2020. Available from: http://www.msp.ua/registration-medicinal-products-ukraine.html
[27]
Regulatory & market profile of Ukraine Pharmexcil 2017. Available from: https://pharmexcil.com/uploads/countryreports/ukraine.pdf
[28]
Bijivemula S, Alagusundaram M, Jayachandra RP. Current trends in follow up procedures with MOH for the registration of the pharmaceutical products. Int J Adv Res. Ideas Innov Tech 2017; 3(3): 1522-31.
[29]
[30]
Regulation of the market for medicinal products in Ukraine: problems and solutions. . 2016. Available from: http://newsep.com.ua/media/news/816/files/Regulations_pharma_eng.PDF
[31]
Jaworski T, Tomasik M, Borkowski L, Buksowicz A, Danevych B. Report on conformity of the process of state registration of medicinal products in Ukraine with the EU law and standards 2020. Available from: https://moz.gov.ua/uploads/0/351-ebrd_project_final_report _eng_2016_11_30.pdf
[33]
State registration of medicinal products in Uzbekistan. . Available from: https://mspcorporate.com/registration-medicinal-products-uzbekistan.html
[34]
List of Documents for Registration Pharmaceutical Product in Republic of Uzbekistan. Available from: http://www.neopass.uz/downloads/registration%20documents_uzb.pdf
[35]
Registration of medicines in Uzbekistan. . Available from: http://en.regmed.uz/submitted_documents.php
[36]
How to Register Medicines in Uzbekistan. Available from: https://pharm.ubi.uz/eng-novosti-4.php
[37]
Drug Management System in The republic of Uzbekistan Siapsprogram. . Available from: http://siapsprogram.org/wp-content/uploads/2013/04/Panel-2.3-Uzbekistan-ENG.pdf
[38]
Registration of medical products (MP) in Uzbekistan and the role of consulting companies in it. Pharm.ubi.uz. 2016. Available from: https://pharm.ubi.uz/eng-novosti-3.php
[40]
State registration of medicinal products in Kazakhstan.. Available from: https://mspcorporate.com/registration-medicinal-products-kazakhstan.html
[41]
Pharmaceutical Market Access in CEE/CIS/Asia Kazakhstan. Regulation of pharmaceutical export Available from: https://cispharma.blogspot.com/2013/01/kazakhstan-regulation-of-pharmaceutical.html
[42]
Overview SCRIBD. 2012. Available from: https://www.scribd.com/document/90626317/KZ-Overview
[43]
Registration Documents Kazakhstan | Pharmaceutical Drug | Pharmacology. SCRIBD.. 2012. Available from: https://www.scribd.com/document/91617678/Registration-Documents-Kazakhstan
[44]
Kazakhstan: pharmaceutical market overview. . Available from: http://khidicis.org/upload/files/38807_864055_17.pdf
[45]
Registration of medical products in the countries of the former Soviet Union (CIS and middle Asia). Available from: https://cratia.ua/en/registration-medical-products-countries-former-soviet-union-cis-and-middle-asia/kazakhstan.html
[46]
Praneetha K, Prakash B, Umasankar K. Study on the regulatory requirements for registration of pharmaceuticals for human use in common wealth of independent states. J Sci 2014; 4(8): 493-7.
[47]
World Health Organization. International Cooperation and Harmonization Available from: https://www.who.int/medicines/areas/quality_safety/regulation_legislation/harmonization/en/
[48]
Gautam V, Irfan M. A Study of procedures for dossier preparation and their marketing authorization in different countries of selected drug(s). Pharma tutor 2017; 5(10): 8-22.
[49]
Growing CIS market holds huge export potential. Available from: http://pharmabiz.com/ArticleDetails.aspx?aid=73006&sid=21
[50]
Deep A, Khurana G. Comparison of basic regulatory requirements for generic drug products registration in CIS and Latin American Countries. Appl Clin Res Clin Trials Regul Aff 2020; 7(1): 5-7.
[51]
Blazhevski V. An analysis of entering the kazakhstan pharmaceutical market: the case of alkaloid. Master’s Thesis Slovenia: University of Ljubljana 2014.
[52]
Regulatory and procedural barriers to trade in Kazakhstan. 2014. Available from: https://www.unece.org/fileadmin/DAM/trade/Publications/ECE-TRADE_407E-Kazakhstan.pdf
[53]
On approval of the rules on importation and exportation of medicines, products of medical purposes and medical equipment 2012. Available from: https://www.wto.org/english/thewto_e/acc_e/kaz_e/WTACCKAZ77A1_LEG_4.pdf
[54]
Ministry of Health of the Republic of Belarus, Center for Examinations and Tests in Health Service, Republican Unitary Enterprise. Available from: https://www.rceth.by/en/About/Activity
[55]
The Georgia Drugs and Narcotics Agency. Available from: https://gdna.georgia.gov/about-us
[56]
Lovells H. Overview of pharmaceuticals regulatory environment in the Russian Federation. Lexology 2008. Available from: https://www.lexology.com/library/detail.aspx?g=88be4cd3-a1c7-4e68-b735-c16d3313f1f7(accessed 20 April 2020)
[57]
Ministry of Health (Tajikistan). Available from: https://en.wikipedia.org/wiki/Ministry_of_Health_(Tajikistan)
[58]
Registration of medical products in the countries of the former Soviet Union (CIS and middle Asia) Available from: https://cratia.ua/en/registration-medical-products-countries-former-soviet-union-cis-and-middle-asia/turkmenistan.html
[59]
Regulatory & market profile of Ukraine. . Available from: https://pharmexcil.com/uploads/countryreports/ukraine.pdf
[60]
Yuldasheva D, Bashirova B, Khamidova O. Uzbekistan: Regulation of the pharmaceutical industry in Uzbekistan.. Available from: https://www.mondaq.com/healthcare/885184/regulation-of-the-pharmaceutical-industry-in-uzbekistan
[61]
Yerevan. Requirements to the Registration of Medicinal products in the Republic of Armenia. Available from: http://armenia.tpo.ir/uploads/Requirements_to_the_State_Registration_28019.pdf
[62]
Registration of medical products in the countries of the former Soviet Union (CIS and middle Asia). Available from: https://cratia.ua/index.php/en/registration-medical-products-countries-former-soviet-union-cis-and-middle-asia/armenia.html
[63]
State registration of medicinal products in Belarus. Available from: https://mspcorporate.com/registration-pharmaceutical-ingridient-belarus.html
[64]
[66]
Registration of medical products in the countries of the former Soviet Union (CIS and middle Asia). . Available from: https://cratia.ua/index.php/en/registration-medical-products-countries-former-soviet-union-cis-and-middle-asia/belarus.html

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy